USD 2.28
(-0.71%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 31.19 Million USD | -13.78% |
2022 | 22.32 Million USD | 14.08% |
2021 | 19.56 Million USD | 70.19% |
2020 | 11.49 Million USD | -20.94% |
2019 | 14.54 Million USD | -8.24% |
2018 | 15.84 Million USD | -5.58% |
2017 | 16.78 Million USD | -18.28% |
2016 | 20.54 Million USD | -8.85% |
2015 | 22.53 Million USD | -13.26% |
2014 | 25.98 Million USD | 20.09% |
2013 | 21.63 Million USD | 66.31% |
2012 | 13 Million USD | 62.9% |
2011 | 7.98 Million USD | -2.2% |
2010 | 8.16 Million USD | 13.63% |
2009 | 7.18 Million USD | -18.04% |
2008 | 8.76 Million USD | -4.5% |
2007 | 9.18 Million USD | 7.77% |
2006 | 8.51 Million USD | 7.13% |
2005 | 7.95 Million USD | 37.99% |
2004 | 5.76 Million USD | 10.56% |
2003 | 5.21 Million USD | -8.48% |
2002 | 5.69 Million USD | 22.04% |
2001 | 4.66 Million USD | -18.19% |
2000 | 5.7 Million USD | -14.86% |
1999 | 6.7 Million USD | -50.74% |
1998 | 13.6 Million USD | -15.0% |
1997 | 16 Million USD | 83.91% |
1996 | 8.7 Million USD | 278.26% |
1995 | 2.3 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.72 Million USD | -7.43% |
2024 Q2 | 4.31 Million USD | 15.75% |
2023 FY | 19.24 Million USD | -13.78% |
2023 Q4 | 4.02 Million USD | -25.82% |
2023 Q3 | 5.42 Million USD | 0.26% |
2023 Q2 | 5.41 Million USD | -1.73% |
2023 Q1 | 5.5 Million USD | 6.54% |
2022 FY | 22.32 Million USD | 14.08% |
2022 Q2 | 5.39 Million USD | -8.61% |
2022 Q1 | 5.9 Million USD | 16.38% |
2022 Q3 | 5.8 Million USD | 7.64% |
2022 Q4 | 5.16 Million USD | -10.99% |
2021 FY | 19.56 Million USD | 70.19% |
2021 Q1 | 3.96 Million USD | 47.38% |
2021 Q3 | 6.71 Million USD | 75.91% |
2021 Q2 | 3.81 Million USD | -3.88% |
2021 Q4 | 5.07 Million USD | -24.42% |
2020 Q3 | 3.03 Million USD | 8.7% |
2020 FY | 11.49 Million USD | -20.94% |
2020 Q1 | 2.97 Million USD | -21.55% |
2020 Q2 | 2.79 Million USD | -6.12% |
2020 Q4 | 2.69 Million USD | -11.3% |
2019 Q1 | 3.27 Million USD | 8.51% |
2019 Q3 | 4 Million USD | 15.54% |
2019 Q2 | 3.46 Million USD | 5.86% |
2019 FY | 14.54 Million USD | -8.24% |
2019 Q4 | 3.79 Million USD | -5.37% |
2018 Q2 | 4.53 Million USD | 5.25% |
2018 FY | 15.84 Million USD | -5.58% |
2018 Q4 | 3.01 Million USD | -24.15% |
2018 Q3 | 3.98 Million USD | -12.29% |
2018 Q1 | 4.31 Million USD | 12.92% |
2017 Q3 | 3.75 Million USD | -12.37% |
2017 Q2 | 4.28 Million USD | -13.14% |
2017 Q4 | 3.81 Million USD | 1.75% |
2017 FY | 16.78 Million USD | -18.28% |
2017 Q1 | 4.92 Million USD | 7.44% |
2016 Q3 | 5.18 Million USD | -4.94% |
2016 Q1 | 5.32 Million USD | 2.63% |
2016 Q2 | 5.45 Million USD | 2.43% |
2016 Q4 | 4.58 Million USD | -11.44% |
2016 FY | 20.54 Million USD | -8.85% |
2015 Q3 | 4.6 Million USD | -23.34% |
2015 Q2 | 6.01 Million USD | -10.67% |
2015 FY | 22.53 Million USD | -13.26% |
2015 Q4 | 5.18 Million USD | 12.49% |
2015 Q1 | 6.73 Million USD | 8.46% |
2014 Q3 | 6.5 Million USD | 3.59% |
2014 Q1 | 6.99 Million USD | -9.08% |
2014 FY | 25.98 Million USD | 20.09% |
2014 Q2 | 6.28 Million USD | -10.16% |
2014 Q4 | 6.2 Million USD | -4.61% |
2013 Q4 | 7.68 Million USD | 62.1% |
2013 FY | 21.63 Million USD | 66.31% |
2013 Q3 | 4.74 Million USD | 3.83% |
2013 Q2 | 4.56 Million USD | -41.84% |
2013 Q1 | 7.85 Million USD | 79.57% |
2012 Q2 | 2.71 Million USD | 27.7% |
2012 Q3 | 3.79 Million USD | 39.72% |
2012 Q4 | 4.37 Million USD | 15.31% |
2012 FY | 13 Million USD | 62.9% |
2012 Q1 | 2.12 Million USD | -2.47% |
2011 Q4 | 2.17 Million USD | 21.18% |
2011 FY | 7.98 Million USD | -2.2% |
2011 Q3 | 1.79 Million USD | -6.54% |
2011 Q2 | 1.92 Million USD | -7.58% |
2011 Q1 | 2.08 Million USD | -3.74% |
2010 Q2 | 2.07 Million USD | -4.37% |
2010 Q3 | 1.76 Million USD | -15.01% |
2010 Q4 | 2.16 Million USD | 22.79% |
2010 FY | 8.16 Million USD | 13.63% |
2010 Q1 | 2.16 Million USD | 9.55% |
2009 Q4 | 1.97 Million USD | -1.41% |
2009 Q3 | 2 Million USD | 22.46% |
2009 Q2 | 1.63 Million USD | 4.99% |
2009 FY | 7.18 Million USD | -18.04% |
2009 Q1 | 1.56 Million USD | 4.63% |
2008 Q1 | 2.31 Million USD | -6.64% |
2008 FY | 8.76 Million USD | -4.5% |
2008 Q2 | 2.89 Million USD | 24.82% |
2008 Q4 | 1.49 Million USD | -27.67% |
2008 Q3 | 2.06 Million USD | -28.72% |
2007 FY | 9.18 Million USD | 7.77% |
2007 Q4 | 2.48 Million USD | 17.15% |
2007 Q3 | 2.11 Million USD | -9.94% |
2007 Q2 | 2.35 Million USD | 5.85% |
2007 Q1 | 2.22 Million USD | 15.68% |
2006 Q2 | 2.26 Million USD | 3.99% |
2006 FY | 8.51 Million USD | 7.13% |
2006 Q4 | 1.92 Million USD | -11.02% |
2006 Q3 | 2.16 Million USD | -4.47% |
2006 Q1 | 2.17 Million USD | -5.25% |
2005 Q3 | 2.12 Million USD | 13.65% |
2005 Q2 | 1.87 Million USD | 12.83% |
2005 FY | 7.95 Million USD | 37.99% |
2005 Q1 | 1.65 Million USD | 24.48% |
2005 Q4 | 2.29 Million USD | 7.91% |
2004 Q1 | 1.42 Million USD | 12.78% |
2004 Q3 | 1.53 Million USD | 4.47% |
2004 Q4 | 1.33 Million USD | -13.16% |
2004 Q2 | 1.46 Million USD | 2.88% |
2004 FY | 5.76 Million USD | 10.56% |
2003 Q1 | 1.52 Million USD | -1.79% |
2003 Q4 | 1.26 Million USD | -11.12% |
2003 Q3 | 1.42 Million USD | 43.11% |
2003 Q2 | 995.05 Thousand USD | -34.85% |
2003 FY | 5.21 Million USD | -8.48% |
2002 Q2 | 1.44 Million USD | 7.31% |
2002 Q1 | 1.35 Million USD | 21.89% |
2002 Q3 | 1.34 Million USD | -7.53% |
2002 Q4 | 1.55 Million USD | 16.03% |
2002 FY | 5.69 Million USD | 22.04% |
2001 Q1 | 1.2 Million USD | -3.71% |
2001 FY | 4.66 Million USD | -18.19% |
2001 Q3 | 1.18 Million USD | 2.07% |
2001 Q2 | 1.16 Million USD | -3.83% |
2001 Q4 | 1.1 Million USD | -6.63% |
2000 Q4 | 1.25 Million USD | -1.52% |
2000 FY | 5.7 Million USD | -14.86% |
2000 Q1 | 1.55 Million USD | 677.3% |
2000 Q3 | 1.27 Million USD | -21.24% |
2000 Q2 | 1.61 Million USD | 4.14% |
1999 Q2 | 2.2 Million USD | -4.35% |
1999 Q1 | 2.3 Million USD | -20.69% |
1999 FY | 6.7 Million USD | -50.74% |
1999 Q4 | 200 Thousand USD | -89.47% |
1999 Q3 | 1.9 Million USD | -13.64% |
1998 Q3 | 2.7 Million USD | -22.86% |
1998 Q2 | 3.5 Million USD | -22.22% |
1998 Q1 | 4.5 Million USD | -4.26% |
1998 FY | 13.6 Million USD | -15.0% |
1998 Q4 | 2.9 Million USD | 7.41% |
1997 Q4 | 4.7 Million USD | 27.03% |
1997 Q1 | 3.8 Million USD | 18.75% |
1997 FY | 16 Million USD | 83.91% |
1997 Q3 | 3.7 Million USD | -5.13% |
1997 Q2 | 3.9 Million USD | 2.63% |
1996 Q1 | 1.4 Million USD | 125.93% |
1996 FY | 8.7 Million USD | 278.26% |
1996 Q3 | 2.4 Million USD | 33.33% |
1996 Q4 | 3.2 Million USD | 33.33% |
1996 Q2 | 1.8 Million USD | 28.57% |
1995 Q4 | -5.4 Million USD | 0.0% |
1995 Q2 | - USD | 0.0% |
1995 Q3 | - USD | 0.0% |
1995 FY | 2.3 Million USD | 0.0% |
1995 Q1 | - USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ontrak, Inc. | 29.47 Million USD | -5.818% |
iCoreConnect Inc. | 15.12 Million USD | -106.227% |
Augmedix, Inc. | 40.3 Million USD | 22.615% |
BrightSpring Health Services, Inc. Common Stock | 1.28 Billion USD | 97.576% |
CareCloud, Inc. | 93.35 Million USD | 66.591% |
CareCloud, Inc. | 93.35 Million USD | 66.591% |
HealthEquity, Inc. | 401.74 Million USD | 92.236% |
Inovalon Holdings, Inc. | 427.99 Million USD | 92.712% |
Nutex Health, Inc. | 66.54 Million USD | 53.132% |
OneMedNet Corporation | 8.24 Million USD | -278.228% |
Progyny, Inc. | 176.61 Million USD | 82.34% |
Omnicell, Inc. | 534.79 Million USD | 94.168% |
Renalytix Plc | 29.04 Million USD | -7.4% |
Schrödinger, Inc. | 318.14 Million USD | 90.196% |
Simulations Plus, Inc. | 37.02 Million USD | 15.748% |
SOPHiA GENETICS SA | 117.73 Million USD | 73.509% |
Minerva Surgical, Inc. | 58.14 Million USD | 46.355% |
GE HealthCare Technologies Inc. | 5.48 Billion USD | 99.432% |
Sharecare, Inc. | 225.97 Million USD | 86.198% |
Aclarion, Inc. | 4.87 Million USD | -539.709% |
CareMax, Inc. | 670.05 Million USD | 95.345% |
Bullfrog AI Holdings, Inc. Common Stock | 5.42 Million USD | -474.685% |
Forian Inc. | 20.59 Million USD | -51.413% |
Bullfrog AI Holdings, Inc. Warrants | 5.42 Million USD | -474.685% |
HeartBeam, Inc. | 15.31 Million USD | -103.67% |
GeneDx Holdings Corp. | 224.28 Million USD | 86.094% |
SCWorx Corp. | 2.71 Million USD | -1046.801% |
Definitive Healthcare Corp. | 546.47 Million USD | 94.293% |
10x Genomics, Inc. | 674.94 Million USD | 95.379% |
Zhongchao Inc. | 13.92 Million USD | -124.026% |
Accolade, Inc. | 306.51 Million USD | 89.824% |
MSP Recovery, Inc. | 565.43 Million USD | 94.484% |
R1 RCM Inc. | 336.6 Million USD | 90.734% |
Spok Holdings, Inc. | 90.97 Million USD | 65.717% |
Privia Health Group, Inc. | 134.31 Million USD | 76.779% |
EUDA Health Holdings Limited | 4.8 Million USD | -549.368% |
TruBridge, Inc. | 206.17 Million USD | 84.872% |
BrightSpring Health Services, Inc. Tangible Equity Unit | 1.28 Billion USD | 97.576% |
Sharecare, Inc. | 225.97 Million USD | 86.198% |
Health Catalyst, Inc. | 258.73 Million USD | 87.945% |
GoodRx Holdings, Inc. | 710.34 Million USD | 95.609% |
Premier, Inc. | 683.65 Million USD | 95.438% |
HealthStream, Inc. | 168.02 Million USD | 81.437% |
Certara, Inc. | 254.08 Million USD | 87.725% |
GeneDx Holdings Corp. | 224.28 Million USD | 86.094% |
Ontrak, Inc. | 29.47 Million USD | -5.818% |
SHL Telemedicine Ltd. | 34.26 Million USD | 8.979% |
CareCloud, Inc. | 93.35 Million USD | 66.591% |
EUDA Health Holdings Limited | 4.8 Million USD | -549.368% |
HeartBeam, Inc. | 15.31 Million USD | -103.67% |
Mangoceuticals, Inc. | 9.65 Million USD | -223.199% |
CareMax, Inc. | 670.05 Million USD | 95.345% |
Healthcare Triangle, Inc. | 18.12 Million USD | -72.083% |
National Research Corporation | 52.52 Million USD | 40.613% |
Aclarion, Inc. | 4.87 Million USD | -539.709% |
OptimizeRx Corporation | 69.3 Million USD | 54.994% |